Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:39 pm Sale | 2021-12-31 | 13G | Standard BioTools Inc. LAB | Russell Investments Group Ltd. | 0 0.000% | -2,250,881 (Position Closed) | Filing History |
| 2022-02-11 4:21 pm Sale | 2021-12-31 | 13G | Standard BioTools Inc. LAB | ORBIMED ADVISORS LLC | 3,416,871 4.460% | -82,375 (-2.35%) | Filing History |
| 2022-02-10 12:24 pm Sale | 2021-12-31 | 13G | Standard BioTools Inc. LAB | PRIMECAP MANAGEMENT CO | 5,093,403 6.660% | -340,440 (-6.27%) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Standard BioTools Inc. LAB | VANGUARD GROUP INC | 3,867,671 5.060% | 391,361 (+11.26%) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Standard BioTools Inc. LAB | BlackRock Inc. BLK | 6,251,230 8.200% | 673,271 (+12.07%) | Filing History |
| 2021-11-18 5:28 pm Sale | 2021-11-18 | 13D | Standard BioTools Inc. LAB | Neuberger Berman Group LLC | 4,336,103 5.670% | -308,451 (-6.64%) | Filing History |
| 2021-05-10 5:20 pm Purchase | 2021-04-30 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 8,380,265 11.200% | 8,380,265 (New Position) | Filing History |
| 2021-02-16 3:33 pm Purchase | 2020-12-31 | 13G | Standard BioTools Inc. LAB | Indaba Capital Management LLC | 7,536,350 9.900% | 257,826 (+3.54%) | Filing History |
| 2021-02-16 12:35 pm Sale | 2020-12-31 | 13G | Standard BioTools Inc. LAB | EASTERLY INVESTMENT PARTNERS LLC | 0 0.000% | -5,128,573 (Position Closed) | Filing History |
| 2021-02-12 4:46 pm Purchase | 2020-12-31 | 13G | Standard BioTools Inc. LAB | ORBIMED ADVISORS LLC | 3,499,246 4.720% | 3,499,246 (New Position) | Filing History |
| 2021-02-12 12:02 pm Sale | 2009-02-28 | 13G | Standard BioTools Inc. LAB | PRIMECAP MANAGEMENT CO | 5,433,843 7.330% | -1,044,000 (-16.12%) | Filing History |
| 2021-02-11 6:34 pm Sale | 2020-12-31 | 13G | Standard BioTools Inc. LAB | Neuberger Berman Group LLC | 4,644,554 6.270% | -1,024,787 (-18.08%) | Filing History |
| 2021-02-10 10:52 am Sale | 2020-12-31 | 13G | Standard BioTools Inc. LAB | VANGUARD GROUP INC | 3,476,310 4.690% | -933,466 (-21.17%) | Filing History |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Standard BioTools Inc. LAB | BlackRock Inc. BLK | 5,577,959 7.500% | 287,638 (+5.44%) | Filing History |